Here are the S-1 registration statements from Exascale Labs Holdings Inc. (XLAB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow XLAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XLAB filings page.
Exascale Labs Holdings Inc. (XLAB) registered for resale by selling securityholders up to 12,350,000 shares of Class A common stock. The company will receive no proceeds from resale sales, but will receive net proceeds if warrants are exercised for cash; 100,000 of the offered shares are issuable upon warrant exercise at $11.50 per share.
Shares outstanding as of October 29, 2026 were 33,689,050 Class A shares and 30,645,739 Class B shares. The company says the registered resale shares represent a substantial percentage of outstanding Class A shares and that selling all of them could significantly reduce the trading price. Its business includes GPU compute and cluster-management services; modular data center, cooling, power, interconnectivity and energy-storage offerings had not generated revenue as of October 30, 2026.
For the fiscal years ended June 30, 2026 and 2025, the company reported net losses of $12.2 million and $7.7 million, respectively, and an accumulated deficit of $25.4 million as of June 30, 2026. It also identified material weaknesses in internal control over financial reporting.